Ginger-derived nanovesicles attenuate osteoarthritis progression by inhibiting oxidative stress via the Nrf2 pathway

Yiming Zeng1, Shun Yu2, Lin Lu3

  • 1Shanghai Key Laboratory of Orthopedic Implants, Department of Orthopedics, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.

PubMed

Insights

Ginger-derived nanovesicles (GDN) show promise for treating osteoarthritis (OA). These nanoparticles promote cartilage health and reduce oxidative stress, offering a potential new therapy for this degenerative joint disease.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Osteoarthritis Research

Background:

  • Osteoarthritis (OA) is a prevalent degenerative joint disease.
  • Ginger-derived nanovesicles (GDN) have demonstrated therapeutic potential in other degenerative conditions.
  • The efficacy of GDN in mitigating OA progression requires investigation.

Purpose of the Study:

  • To investigate the therapeutic potential of ginger-derived nanovesicles (GDN) in osteoarthritis (OA).
  • To evaluate the effects of GDN on chondrocytes, an OA rat model, and human OA cartilage explants.

Main Methods:

  • GDN were isolated and characterized.
  • The effects of GDN were assessed in tert-butyl hydroperoxide (TBHP)-induced chondrocytes.
  • GDN efficacy was evaluated in a post-traumatic OA rat model and ex vivo human OA cartilage explants.

Main Results:

  • GDN promoted cartilage anabolism and alleviated oxidative stress in both cellular and animal models of OA.
  • GDN demonstrated protective effects on ex vivo cultured human OA cartilage.
  • The Nrf2 pathway was identified as a mechanism underlying the protective effects of GDN.

Conclusions:

  • Ginger-derived nanovesicles (GDN) exhibit significant potential for the treatment of osteoarthritis.
  • GDN promote cartilage health and combat oxidative stress, key factors in OA.
  • Further research into GDN as an OA therapeutic is warranted.

Related Concept Videos